Hisahiro Yoshida Selected Research

Hisahiro Yoshida Research Topics

Disease

7	Neoplasms (Cancer) 11/2016 - 01/2002
2	Dermatitis 01/2016 - 08/2010
2	Inflammation (Inflammations) 08/2010 - 04/2010
2	Breast Neoplasms (Breast Cancer) 02/2005 - 01/2004
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2005 - 01/2004
2	Ectodermal Dysplasia (Aplasia Cutis Congenita) 09/2002 - 06/2002
1	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2019
1	Schizophrenia (Dementia Praecox) 01/2019
1	Hyperammonemia 01/2017
1	Communicable Diseases (Infectious Diseases) 01/2016
1	Hypersensitivity (Allergy) 01/2016
1	Pain (Aches) 01/2016
1	Lymphopenia (Lymphocytopenia) 08/2014
1	Diarrhea 01/2013
1	Lung Neoplasms (Lung Cancer) 01/2013
1	Skin Diseases (Skin Disease) 08/2010
1	Atopic Dermatitis (Atopic Eczema) 08/2010
1	Fibrosarcoma 04/2010
1	Pathologic Processes 12/2009
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2005
1	Intermittent Claudication 11/2004
1	Hypertrophy 03/2003
1	Colitis 03/2003
1	Osteopetrosis 01/2003
1	Carcinoma (Carcinomatosis) 01/2002

Drug/Important Bio-Agent (IBA)

6	Irinotecan (Camptosar)FDA LinkGeneric 01/2013 - 01/2002
6	Proteins (Proteins, Gene)FDA Link 08/2010 - 06/2002
3	Complementary DNA (cDNA)IBA 02/2005 - 01/2002
2	Immunoglobulin E (IgE)IBA 01/2016 - 08/2010
2	Gefitinib (Iressa)FDA Link 01/2013 - 02/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2010 - 09/2002
2	Mitoxantrone (Novantrone)FDA LinkGeneric 02/2005 - 01/2004
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 07/2004 - 04/2004
2	CamptothecinIBA 07/2004 - 01/2004
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 04/2004 - 01/2002
2	Adenosine Triphosphate (ATP)IBA 01/2004 - 01/2002
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2019
1	Antipsychotic Agents (Antipsychotics)IBA 01/2019
1	Amino Acids FDA Link 01/2017
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2017
1	Urea (Carbamide)FDA LinkGeneric 01/2017
1	thiazolyl blueIBA 11/2016
1	AgarIBA 01/2016
1	VaccinesIBA 01/2016
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2016
1	GelatinIBA 01/2016
1	AntigensIBA 01/2016
1	Peptide Hydrolases (Proteases)FDA Link 01/2016
1	Analgesics (Analgesic Drugs)IBA 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	Local AnestheticsIBA 01/2016
1	Ointments (Pastes)IBA 01/2016
1	ZincIBA 08/2014
1	LactonesIBA 01/2013
1	B-Cell Activating FactorIBA 08/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2010
1	CytokinesIBA 04/2010
1	MethylcholanthreneIBA 04/2010
1	Calcium-Independent Phospholipases A2IBA 12/2009
1	Phospholipases (Phospholipase)IBA 12/2009
1	CalciumIBA 12/2009
1	ErbB Receptors (EGF Receptor)IBA 02/2005
1	Tyrosine Kinase InhibitorsIBA 02/2005
1	Topoisomerase I InhibitorsIBA 02/2005
1	Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA 11/2004
1	Antineoplastic Agents (Antineoplastics)IBA 07/2004
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 07/2004
1	trioctyl phosphine oxide (TOPO)IBA 07/2004
1	Novobiocin (Streptonivicin)FDA Link 01/2004
1	Topotecan (Hycamtin)FDA LinkGeneric 01/2004
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2004
1	coumermycinIBA 01/2004
1	HaptensIBA 03/2003
1	Lymphotoxin beta ReceptorIBA 03/2003
1	Macrophage Colony-Stimulating FactorIBA 01/2003
1	EctodysplasinsIBA 09/2002
1	Cell Adhesion Molecule-1IBA 09/2002
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 09/2002
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 09/2002
1	Ectodysplasin ReceptorsIBA 06/2002
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 06/2002
1	Edar ReceptorIBA 06/2002

Therapy/Procedure

1	Stem Cell Transplantation 03/2019
1	Dental Care 01/2016
1	Immunotherapy 01/2016
1	Subcutaneous Injections 04/2010
1	Drug Therapy (Chemotherapy) 07/2004